Professor Brydie-Leigh Bartleet (Director, Queensland Conservatorium Research Centre, Griffith University) has just been awarded a highly competitive Arts for Good Fellowship by the Singapore International Foundation.
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.
Griffith University will partner with a Chinese pharmaceutical for a new vaccine that has enormous potential to help millions. Clinical trials of the new, needle-free vaccine is targeted at Streptococcus A infection, the cause of strep throat and rheumatic heart disease and many other illnesses.
Griffith University microbiologist Dr Kate Seib has been recognised for her distinguished contributions to microbiology research in Australia, including vaccine targets for diseases which cause meningitis, gonorrhoea and middle ear infections.